Indicators of intracardiac haemodynamics in patients with chronic coronary syndrome with concomitant coronavirus disease (COVID-19)

Keywords: Echocardiography, Coronary Artery Disease (CAD), Troponin I, SARS-Cov-2, COVID-19, global longitudinal strain speckle tracking echocardiography

Abstract

the nature of cardiovascular damage caused by SARS-CoV-2 coronavirus infection due to acute severe respiratory distress syndrome is associated with high mortality. However, the pathophysiological impact of COVID-19 (C19) on intracardiac haemodynamics remains unknown. The aim of our study was to evaluate intracardiac haemodynamics in patients with chronic coronary syndrome (CCS) in combination with coronavirus disease (COVID-19). The prospective study included: 30 patients with CAD with a negative PCR test for COVID-19 (1Agroup), 38 patients with CAD with a positive PCR test for COVID-19 (1Bgroup), of whom 12 were diagnosed with an increase in the level of troponin I (1B/T+), 26 patients had a normal level of troponin I (1B/T-). As a comparison, 30 patients with COVID-19 with PCR(+), without signs of CAD - group 2, as well as 30 healthy volunteers without signs of CAD and with negative PCR were studied. Clinical and laboratory data, treatment, and intracardiac haemodynamics were assessed by echocardiography in all groups. The left ventricular myocardial mass index, left ventricular end-diastolic volume, right ventricular size, and pulmonary artery systolic pressure were highest in the group of CAD with COVID-19 with a positive troponin test (1B/T+), compared with the (1B/T-) group, also in the (1B/T+) group, the ejection fraction and total longitudinal strain by speckle tracking were lower than in the (1B/T-) group. When compared with group 1A, LVEF was lower in the (1B/T+) group, and STla was higher in the (1B/T+) group. When comparing the indicators of group 1A and (1B/T-), a similar pattern of changes in intracardiac haemodynamics was noted: LV myocardial mass index, right ventricular diameter, systolic pressure in the pulmonary artery were higher, while longitudinal strain was slightly lower in (1B/T-) than in group 1A.  When comparing the echocardiography parameters of patients in the (1B/T+) subgroup with group 2, larger left ventricular end-diastolic volume, left atrium, left ventricular myocardial mass index were found in (1B/T+), but the ejection fraction was lower in (1B/T+), while the right ventricular size and pulmonary artery systolic pressure were slightly higher than in group 2. In the subgroup (1B/T-), the nature of the changes was similar, but the size of the RV and PASP did not differ from those in group 2. The echocardiographic parameters of group 1A differed from those of group 2 by higher values of LVEF, LVEDV, LVMMS and lower EF, but the size of the RV and PASP were larger in patients with COVID-19.  Cardiac damage associated with SARS-CoV-2 in patients with concomitant CAD has an effect on the myocardium, which is manifested in an increase in left ventricular EF due to increased preload, at the expense of a decrease in global strain and systolic function of the LV myocardium, due to the direct cytotoxic effect of SARS-CoV-2 on the one hand, and destabilisation of existing atherosclerotic plaques, as well as hypoxia and worsening of endothelial dysfunction on the other.  An increase in the size of the right ventricle is associated with an increase in peripheral vascular resistance in the small circle as a consequence of increased systolic pressure in the pulmonary artery in covidassociated pneumonia. The impact of SARS-CoV-2 infection on the heart is associated with cardiovascular risk factors and the severity of the inflammatory process.

References

Argulian E., Sud K., Vogel B. (2020). Right ventricular dilation in hospitalized patients with COVID-19 infection. JACC Cardio- vasc Imaging. 2020 Nov, 13, (11), 2459-2461. Epub 2020 May 15.

https://doi.org/10.1016/j.jcmg.2020.05.010

Bangalore S., Sharma A., Slotwiner A. (2020). ST-segment elevation in patients with Covid-19 a Case Series. N Engl J Med. 2020 Jun 18, 382(25), 2478-2480. https://doi.org/10.1056/NEJMc2009020

Bonow R.O., Fonarow G.C., O’Gara P.T., Yancy C.W. (2020). Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020, 5(7), 751-753. https://doi.org/10.1001/ jamacardio.2020.1105

Chen C., Zhou Y., Wang D.W. (2020). SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz 2020 May, 45(3), 230-232. https://doi: 10.1007/s00059-020-04909-z.

Conti P., Ronconi G., Caraffa A. (2020). Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020, 34(2), 327-331. https://doi:10.23812/CONTI-E.

Fan H., Zhang L., Huang B. (2020). Cardiac injuries in patients with coronavirus disease 2019: not to be ignored. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020 Jul, 96, 294–297. Published online 2020 May 11. https://doi: 10.1016/j.ijid.2020.05.024

De Filippo O, D’Ascenzo F, Angelini F. (2020). Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy. N Engl J Med. 2020 Jul 2, 383(1), 88-89. Epub 2020 Apr 28. https://doi.org/10.1056/NEJMc 2009166

Fox SE, Akmatbekov A, Harbert JL. (2020). Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med. 2020 Jul, 8(7), 681-686. Epub 2020 May 27. https://doi.org/10.1016/S2213-2600(20)30243-5

Grillet F., Behr J., Calame P. (2020) .Acute pulmonary embolism associated with COVID-19 pneumonia detected by pulmonary CT angiography. Radiology. 2020 Sep, 296(3), E186-E188. https://doi.org/10.1148/radiol.2020201544

Guan W-J., Ni Z-Y., Hu Y. (2020). Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. April 30, 2020. N Engl J Med 2020, 382,1708-1720. https://doi. org/10.1056/NEJMoa2002032

Guo T., Fan Y., Chen M. (2020). Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020, 5(7), 811-818. https://doi.org/10.1001/jamacardio .2020.1017

Hu H., Ma F., Wei X., Fang Y. (2020). Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 7 January 2021. Volume 42. Issue 2. Page 206. https://doi.org/10.1093/eurheartj/ehaa190

Haddad F., Hunt S.A., Rosenthal D.N., Murphy D.J. (2008). Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation.

Mar 18, 117(11), 1436-48. https://doi.org/10.1161/CIRCU LATIONAHA.107.653576

Huang C., Wang Y., Li X. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15, 395(10223), 496 https://doi.org/10.1016/S0140-6736(20)30183-5

Huang L., Zhao P., Tang D. (2020). Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020 Nov, 13, (11), 2330–2339. https://doi. org/10.1016/j.jcmg.2020.05.004

Inciardi R.M., Adamo M., Lupi L. (2020). Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020, May 14, 41(19),1821-1829. https://doi. org/10.1093/eurheartj/ehaa388

Inciardi R.M., Lupi L., Zaccone G. (2020). Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1, 5(7), 819-824. https://doi.org/10.1001/jamacardio.2020.1096

Knight D.S., Kotecha T., Razvi Y. (2020). COVID-19: myocardial injury in survivors. Circulation. 2020 Sep 15,142(11),1120-1122. Epub 2020 Jul 14.https://doi.org/10.1161/ CIRCULATIONAHA.120.049252

Olivier Lairez, Virginie Blanchard, Valérie Houard. (2021). Cardiac imaging phenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study The International Journal of Cardiovascular Imaging 2021, 37(2), 449–457. https://doi.org/10.1007/s10554-020-02010-4

Lang R.M., Badano L.P., Mor-Avi V. (2015). Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16, 233–270. https://doi.org/10.1093/ehjci/ jev014

Li Y., Li H., Zhu S. (2020). Prognostic value of right ventricular longitudinal strain in patients with COVID-19. JACC Cardiovasc Imaging. 2020 Nov, 13, (11), 2287-2299. Epub 2020 Apr 28. https://doi.org/10.1016/j.jcmg.2020.04.014

Lindner D., Fitzek A., Bräuninger H. (2020). Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020 Nov. 1, 5(11), 1281-1285. https://doi.org/10.1001/jamacardio .2020.3551

Lippi G., Lavie C.J., Sanchis-Gomar F. (2020). Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis. 2020 May-Jun, 63(3), 390-391. Epub 2020 Mar 10.https://doi. org/10.1016/j.pcad.2020.03.001

Nagueh S.F., Smiseth O.A., Appleton C.P. (2016). Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17, 1321–1360. https ://doi.org/10.1093/ehjci/jew082

Puntmann V.O., Carerj M.L., Wieters I. (2020). Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol.

, 5(11), 1265-1273. https://doi.org/10.1001/jamacardio.2020.3557

Russell K., Eriksen M., Aaberge L. (2013). Assessment of wasted myocardial work: a novel method to quantify energy loss due to uncoordinated left ventricular contractions. Am J Physiol Heart Circ Physiol. 2013 Oct 1, 305(7), H996-1003. Epub 2013 Jul 26.https://doi.org/10.1152/ ajpheart.00191.2013

Shi S., Qin M., Shen B. (2020). Association of cardiac injury with mortality in hospitalized patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020, 5(7), 802-810. https://doi.org/10.1001/jamacardio .2020.0950

Solomon M.D., McNulty E.J., Rana J.S. (2020). The Covid-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med. 2020 Aug 13, 383(7), 691-693. Epub 2020 May 19.

https://doi.org/10.1056/NEJMc2015630

Tang N., Li D., Wang X., Sun Z. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 Apr,18(4), 844-847. Epub 2020 Mar 13. https://doi.org/10.1111/jth.14768

Varga Z., Flammer A.J., Steiger P. (2020). Endothelial cell infection and endotheliitis in COVID-19. Lancet Lancet. 2020 May 2, 395(10234), 1417-1418. Epub 2020 Apr 21. https://doi: 10.1016/S0140-6736(20)30937-5.

Voigt J-U, Pedrizzetti G, Lysyansky P. (2015). Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2015 Jan,16(1),1-11. Epub 2014 Dec 18.

https://doi.org/10.1093/ehjci/jeu184

Wei J-F, Huang F-Y, Xiong T-Y. (2020). Acute myocardial injury is common in patients with covid-19 and impairs their prognosis. Heart. 2020, (106), 1122-1124. Published Online First: 30 Apr 2020. https://doi.org/10.1136/heartjnl-2020-317007

World Health Organization (2020). WHO Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. WHO, Geneva.

Yang X., Yu Y., Xu J. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May, 8(5), 475-481. Epub 2020 Feb 24. https://doi.org/10.1016/S2213-2600(20)30079-5

Zhang J-J., Dong X., Cao Y-Y. (2020). Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020 Jul, 75(7), 1730-1741. Epub 2020 Feb 27. https://doi.org/10.1111/all.14238

Zheng Y-Y., Ma Y-T., Zhang J-Y., Xie X. (2020). COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 May,17(5), 259-260. https://doi.org/10.1038/ s41569-020-0360-5

Published
2024-03-28
How to Cite
Netiazhenko , V., Mostovyi , S., Potashov , S., & Safonova , O. (2024). Indicators of intracardiac haemodynamics in patients with chronic coronary syndrome with concomitant coronavirus disease (COVID-19). The Ukrainian Scientific Medical Youth Journal, 144(1), 26-37. https://doi.org/10.32345/USMYJ.1(144).2024.26-37
Section
CONFERENCE IS DEDICATED TO THE MEMORY TEACHER O.Y. HRYTSYUK